Used as a chiral intermediate in the synthesis of pharmaceuticals, particularly in the production of active pharmaceutical ingredients (APIs) requiring high enantiomeric purity. Its structure supports the development of neuroactive and cardiovascular drugs, where the (R)-enantiomer contributes to desired biological activity. Commonly employed in asymmetric synthesis routes due to its stable stereocenter and functional group compatibility. Also utilized in the preparation of fluorinated analogs in medicinal chemistry for improved metabolic stability and bioavailability.